Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Wong Mito Lab, |
RCV000850907 | SCV000993141 | pathogenic | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | 2019-07-12 | criteria provided, single submitter | clinical testing | The NC_012920.1:m.7512T>C variant in MT-TS1 gene is interpreted to be a Pathogenic variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes reported in the guidelines: PS3, PS5, PP3 |
Mendelics | RCV002247286 | SCV002517729 | pathogenic | Cytochrome-c oxidase deficiency disease | 2022-05-04 | criteria provided, single submitter | clinical testing | |
MGZ Medical Genetics Center | RCV000010174 | SCV002562247 | likely pathogenic | MERRF/MELAS overlap syndrome | 2022-06-30 | criteria provided, single submitter | clinical testing | VAF 50% heteroplasmy in blood, several affected family members |
OMIM | RCV000010174 | SCV000030395 | pathogenic | MERRF/MELAS overlap syndrome | 1998-11-01 | no assertion criteria provided | literature only | |
OMIM | RCV000010175 | SCV000030396 | pathogenic | Mitochondrial cytochrome c oxidase deficiency | 1998-11-01 | no assertion criteria provided | literature only | |
Gene |
RCV000850907 | SCV004042621 | not provided | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | no assertion provided | literature only |